Edition:
United Kingdom

Apollo Endosurgery Inc (APEN.OQ)

APEN.OQ on NASDAQ Stock Exchange Global Market

3.44USD
24 May 2019
Change (% chg)

$-0.06 (-1.85%)
Prev Close
$3.51
Open
$3.55
Day's High
$3.55
Day's Low
$3.30
Volume
5,337
Avg. Vol
3,602
52-wk High
$9.56
52-wk Low
$3.05

Latest Key Developments (Source: Significant Developments)

Apollo Endosurgery Inc Announces Sale Of Its Surgical Product Line
Tuesday, 18 Dec 2018 

Dec 18 (Reuters) - Apollo Endosurgery Inc ::PRESS RELEASE - APOLLO ENDOSURGERY, INC. ANNOUNCES THE SALE OF ITS SURGICAL PRODUCT LINE.APOLLO ENDOSURGERY INC - DEFINITIVE TRANSACTION AGREEMENTS WERE SIGNED AND CLOSED SIMULTANEOUSLY YESTERDAY, DECEMBER 17, 2018..APOLLO ENDOSURGERY INC - ANNOUNCED SALE OF ITS SURGICAL PRODUCT LINE TO RESHAPE LIFESCIENCES INC..APOLLO ENDOSURGERY INC - APOLLO RECEIVED CASH OF $10 MILLION AND RESHAPE'S INTRA-GASTRIC BALLOON PRODUCT LINE.APOLLO ENDOSURGERY INC - USED UPFRONT CASH PROCEEDS FROM RESHAPE OF $10 MILLION TO PAY DOWN ITS BORROWINGS UNDER ITS SENIOR SECURED CREDIT FACILITY.APOLLO ENDOSURGERY INC - APOLLO WILL CONTINUE TO MANUFACTURE SURGICAL PRODUCT LINE FOR RESHAPE FOR UP TO TWO YEARS.APOLLO ENDOSURGERY INC - APOLLO WILL CONTINUE DISTRIBUTING PRODUCTS IN THE SURGICAL PRODUCT LINE IN MARKETS OUTSIDE UNITED STATES FOR UP TO 12 MONTHS.  Full Article

Apollo Endosurgery Q4 Loss Per Share $0.42
Thursday, 1 Mar 2018 

March 1 (Reuters) - Apollo Endosurgery Inc ::APOLLO ENDOSURGERY, INC. REPORTS FOURTH QUARTER AND FULL YEAR 2017 RESULTS.Q4 REVENUE ROSE 5 PERCENT TO $16.1 MILLION.QTRLY LOSS PER SHARE $0.42.  Full Article

Apollo Endosurgery Announces MFDS Approval For Orbera Intragastric Balloon System
Thursday, 22 Feb 2018 

Feb 22 (Reuters) - Apollo Endosurgery Inc ::APOLLO ENDOSURGERY ANNOUNCES MFDS APPROVAL FOR ORBERA INTRAGASTRIC BALLOON SYSTEM IN SOUTH KOREA, A NON-SURGICAL SOLUTION TO ASSIST PATIENTS WITH WEIGHT LOSS.  Full Article

Apollo Endosurgery Inc Files For Stock Shelf Of Upto $50 Million - SEC Filing ‍​
Monday, 4 Dec 2017 

Dec 4 (Reuters) - Apollo Endosurgery Inc ::APOLLO ENDOSURGERY INC FILES FOR STOCK SHELF OF UPTO $50 MILLION - SEC FILING ‍​.  Full Article

Apollo Endosurgery Receives FDA Clearance For Overstitch Sx Endoscopic Suturing System
Monday, 27 Nov 2017 

Nov 27 (Reuters) - Apollo Endosurgery Inc ::APOLLO ENDOSURGERY RECEIVES FDA CLEARANCE FOR OVERSTITCH™ SX ENDOSCOPIC SUTURING SYSTEM.APOLLO ENDOSURGERY INC - ‍U.S. FOOD AND DRUG ADMINISTRATION 510K CLEARANCE OF OVERSTITCH SX​.APOLLO ENDOSURGERY INC - ‍PLANS TO INTRODUCE SX SYSTEM IN US AND EUROPE IN FIRST HALF OF 2018​.  Full Article

Apollo Endosurgery reports qtrly loss per share $‍0.32​
Thursday, 26 Oct 2017 

Oct 26 (Reuters) - Apollo Endosurgery Inc :Apollo Endosurgery Inc reports third quarter 2017 results.Q3 sales $16.5 million versus I/B/E/S view $16.7 million.Apollo Endosurgery Inc - qtrly loss per share $‍0.32​.  Full Article

Apollo endosurgery announces CE mark approval for the Orbera365™ managed weight loss system,
Wednesday, 30 Aug 2017 

Aug 31 (Reuters) - Apollo Endosurgery Inc :Apollo Endosurgery announces CE mark approval for the Orbera365™ managed weight loss system, expanding the indwell period from 6 months to 12 months with the gastric balloon category leader.Apollo Endosurgery Inc - ‍Company expects Orbera365 to be commercially available starting in Q4 of 2017​.Apollo Endosurgery - ‍Approval enables Apollo to market and sell Orbera365 weight loss balloon in European Union and European economic area member countries​.  Full Article

Stonepine Capital Management Llc reports 13.7 percent passive stake in Apollo Endosurgery Inc
Friday, 18 Aug 2017 

Aug 18 (Reuters) - Stonepine Capital Management LLC::Stonepine Capital Management Llc reports 13.7 percent passive stake in Apollo Endosurgery Inc as of August 11, 2017 - SEC filing‍​.  Full Article

Novo Holdings A/S reports 3.9 pct stake in Apollo Endosurgery as on Aug 14
Wednesday, 16 Aug 2017 

Aug 16 (Reuters) - Apollo Endosurgery Inc :Novo Holdings A/S reports 3.9 percent stake in Apollo Endosurgery Inc as on August 14, 2017 - SEC filing‍​.Novo Holdings A/S had previously reported 6.3 percent stake in Apollo Endosurgery Inc as on August 10, 2017.  Full Article

Apollo Endosurgery Q2 revenue $17.1 mln
Tuesday, 1 Aug 2017 

Aug 1 (Reuters) - Apollo Endosurgery Inc :Apollo Endosurgery reports second quarter 2017 results.Q2 revenue $17.1 million.Apollo Endosurgery - total endo-bariatric revenues were $9.5 million for three months ended june 30, 2017, an increase of 13.0% compared to q2 of 2016.Qtrly loss per share $0.64.  Full Article